Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-157-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-01-19"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pl"^^xsd:language2
lpv:document identification number	"en.20110119.20.3-157-000"2
lpv:hasSubsequent	lp_eu:2011-01-19-Speech-3-158-0002
lpv:speaker	lp:Adam Bielan2
lpv:spokenAs	vice-chair; PECH (2010-02-18--2011-12-12)3 substitute; AFET (2009-09-07--2012-01-18)3 member; IMCO (2009-07-16--2012-01-18)3 substitute; Delegation to the EU-Mexico Joint Parliamentary Committee (2009-09-16--2011-12-28)3 unknown; Prawo i Sprawiedliwość (2009-07-14--2011-02-20)3 member; Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN) (2009-09-16--2014-06-30)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"Madam President, I voted in favour of the directive presented by Mrs Grossetête, so that the principle of cross-border treatment in the European Union can finally be put into practice after many years of negotiations. I regard the directive in its current form as a good compromise, based predominantly on patients’ rights, but also protecting the interests of the national health funds of the Member States. For citizens of countries such as Poland, the opportunity to receive treatment abroad means equal opportunities when it comes to benefiting from modern healthcare. Patients are often deprived of access to rapid and appropriate healthcare as a result of overcrowded hospitals, long queues and waiting lists for certain key procedures. Time is a huge factor in some cases. The directive will make it possible for citizens to decide for themselves whether to wait many months for the procedure to be carried out in their own country, or whether to choose somewhere else to receive treatment. It will be easier for them to decide how to be treated if they are aware of the fact that the costs of the procedure will also be reimbursed – at least to a large extent, and sometimes even entirely – if it is carried out in another European Union Member State. Simplifying the rules governing treatment abroad can, of course, also be seen as mobilising market forces in terms of general access to medical services. In my opinion, therefore, these solutions will help increase the competitiveness of health services and, as a result, also have a significant impact in terms of speeding up improvements in such services."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph